Bilirubin removal by anion exchange resin in post-operative liver failure

M. Miyazaki, K. Sakagami, S. Shiozake, Shinya Saito, Junji Matsuoka, K. Orita

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Extended surgery has become a common therapy for malignant tumors in hepatobilialy and the pancreatic region to obtain higher radicalities. Accordingly, post-operative hepatic failure is occurring more frequently. So a hepatic support therapy including plasma exchange (PE) (1), direct hemoperfusion over adsorbent such as charcoal (2) and hemofiltration (3) has been clinically applied. A description is given of plasma perfusion (PP) over BR-601, an anion exchange resin, as well as the removability for bilirubin and bile acids in patients with serious postoperative hepatic failure.

Original languageEnglish
Pages (from-to)977-983
Number of pages7
JournalBiomaterials, Artificial Cells, and Artificial Organs
Volume16
Issue number5
Publication statusPublished - 1988

Fingerprint

Anion Exchange Resins
Liver Failure
Bilirubin
Liver
Ion exchange
Negative ions
Resins
Plasmas
Hemoperfusion
Hemofiltration
Plasma Exchange
Charcoal
Bile Acids and Salts
Adsorbents
Surgery
Tumors
Perfusion
Acids
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Bilirubin removal by anion exchange resin in post-operative liver failure. / Miyazaki, M.; Sakagami, K.; Shiozake, S.; Saito, Shinya; Matsuoka, Junji; Orita, K.

In: Biomaterials, Artificial Cells, and Artificial Organs, Vol. 16, No. 5, 1988, p. 977-983.

Research output: Contribution to journalArticle

@article{5bf438de59d54a86b04608fbeae6f65c,
title = "Bilirubin removal by anion exchange resin in post-operative liver failure",
abstract = "Extended surgery has become a common therapy for malignant tumors in hepatobilialy and the pancreatic region to obtain higher radicalities. Accordingly, post-operative hepatic failure is occurring more frequently. So a hepatic support therapy including plasma exchange (PE) (1), direct hemoperfusion over adsorbent such as charcoal (2) and hemofiltration (3) has been clinically applied. A description is given of plasma perfusion (PP) over BR-601, an anion exchange resin, as well as the removability for bilirubin and bile acids in patients with serious postoperative hepatic failure.",
author = "M. Miyazaki and K. Sakagami and S. Shiozake and Shinya Saito and Junji Matsuoka and K. Orita",
year = "1988",
language = "English",
volume = "16",
pages = "977--983",
journal = "Artificial Cells, Nanomedicine and Biotechnology",
issn = "2169-1401",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Bilirubin removal by anion exchange resin in post-operative liver failure

AU - Miyazaki, M.

AU - Sakagami, K.

AU - Shiozake, S.

AU - Saito, Shinya

AU - Matsuoka, Junji

AU - Orita, K.

PY - 1988

Y1 - 1988

N2 - Extended surgery has become a common therapy for malignant tumors in hepatobilialy and the pancreatic region to obtain higher radicalities. Accordingly, post-operative hepatic failure is occurring more frequently. So a hepatic support therapy including plasma exchange (PE) (1), direct hemoperfusion over adsorbent such as charcoal (2) and hemofiltration (3) has been clinically applied. A description is given of plasma perfusion (PP) over BR-601, an anion exchange resin, as well as the removability for bilirubin and bile acids in patients with serious postoperative hepatic failure.

AB - Extended surgery has become a common therapy for malignant tumors in hepatobilialy and the pancreatic region to obtain higher radicalities. Accordingly, post-operative hepatic failure is occurring more frequently. So a hepatic support therapy including plasma exchange (PE) (1), direct hemoperfusion over adsorbent such as charcoal (2) and hemofiltration (3) has been clinically applied. A description is given of plasma perfusion (PP) over BR-601, an anion exchange resin, as well as the removability for bilirubin and bile acids in patients with serious postoperative hepatic failure.

UR - http://www.scopus.com/inward/record.url?scp=0024218205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024218205&partnerID=8YFLogxK

M3 - Article

C2 - 3252937

AN - SCOPUS:0024218205

VL - 16

SP - 977

EP - 983

JO - Artificial Cells, Nanomedicine and Biotechnology

JF - Artificial Cells, Nanomedicine and Biotechnology

SN - 2169-1401

IS - 5

ER -